0.44
price down icon4.35%   -0.02
 
loading
前日終値:
$0.46
開ける:
$0.4654
24時間の取引高:
3.25M
Relative Volume:
0.36
時価総額:
$10.50M
収益:
$62.71M
当期純損益:
$-10.48M
株価収益率:
-0.6984
EPS:
-0.63
ネットキャッシュフロー:
$-13.77M
1週間 パフォーマンス:
+42.49%
1か月 パフォーマンス:
-5.27%
6か月 パフォーマンス:
-81.67%
1年 パフォーマンス:
-93.20%
1日の値動き範囲:
Value
$0.3782
$0.51
1週間の範囲:
Value
$0.33
$0.595
52週間の値動き範囲:
Value
$0.2179
$7.48

Prophase Labs Inc Stock (PRPH) Company Profile

Name
名前
Prophase Labs Inc
Name
セクター
Healthcare (1166)
Name
電話
(215) 345-0919
Name
住所
711 STEWART AVE, SUITE 200, NEW YORK, PA
Name
職員
113
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
PRPH's Discussions on Twitter

PRPH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
PRPH
Prophase Labs Inc
0.44 10.50M 62.71M -10.48M -13.77M -0.63
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
500.16 196.14B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.85 150.17B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
415.87 34.36B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
116.69 33.28B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
177.39 31.62B 15.41B 1.37B 2.11B 7.50

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-12-20 開始されました H.C. Wainwright Buy
2021-10-13 ダウングレード Dawson James Buy → Neutral
2021-01-20 開始されました Dawson James Buy

Prophase Labs Inc (PRPH) 最新ニュース

pulisher
Mar 28, 2025

ProPhase Labs (PRPH) Set to Announce FY Earnings, Faces Challenges - GuruFocus.com

Mar 28, 2025
pulisher
Mar 28, 2025

An Overview of ProPhase Labs's Earnings - Benzinga

Mar 28, 2025
pulisher
Mar 27, 2025

ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - The Manila Times

Mar 27, 2025
pulisher
Mar 20, 2025

ProPhase Labs (PRPH) Projected to Post Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 07, 2025

ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th - Nasdaq

Mar 07, 2025
pulisher
Mar 07, 2025

ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Can ProPhase Labs Convince Investors? CEO Reveals Strategic Vision Next Week - StockTitan

Mar 07, 2025
pulisher
Mar 05, 2025

Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

ProPhase Labs, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 26, 2025

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News

Feb 26, 2025
pulisher
Feb 26, 2025

Deeper Dive: Understanding ProPhase Labs Inc (PRPH) Through its Various Ratios - The Dwinnex

Feb 26, 2025
pulisher
Feb 25, 2025

ProPhase Labs Examines Strategic Opportunities to Leverage - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

ProPhase Labs Focuses On Telehealth And DTC Marketing For Prescription Drug Growth Strategy - Nasdaq

Feb 25, 2025
pulisher
Feb 25, 2025

ProPhase Labs examines opportunities to leverage DTC multi-media infrastructure - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Can ProPhase's Telehealth Pivot Save Its Stock From Delisting? Company Says No Reverse Split Needed - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

ProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.com - Defense World

Feb 25, 2025
pulisher
Feb 25, 2025

ProPhase sharpens focus on direct-to-consumer growth - Investing.com

Feb 25, 2025
pulisher
Feb 21, 2025

ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks

Feb 21, 2025
pulisher
Feb 20, 2025

ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

ProPhase Labs hires Stuart Hollenshead as COO - TipRanks

Feb 19, 2025
pulisher
Feb 18, 2025

ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria

Feb 18, 2025
pulisher
Feb 18, 2025

ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire

Feb 18, 2025
pulisher
Feb 18, 2025

ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com

Feb 18, 2025
pulisher
Feb 18, 2025

ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha

Feb 18, 2025
pulisher
Feb 18, 2025

ProPhase Labs appoints Stu Hollenshead as COO - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan

Feb 18, 2025
pulisher
Feb 17, 2025

ProPhase Labs FY2024 EPS Estimate Reduced by Diamond Equity - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

ProPhase Labs (NASDAQ:PRPH) Now Covered by StockNews.com - Defense World

Feb 17, 2025
pulisher
Feb 14, 2025

ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

ProPhase Labs Appoints New Chief Operating Officer - TipRanks

Feb 14, 2025
pulisher
Feb 13, 2025

ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa

Feb 13, 2025
pulisher
Feb 13, 2025

ProPhase Labs appoints new COO amid executive changes - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Why AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 13, 2025
pulisher
Feb 11, 2025

StockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World

Feb 11, 2025
pulisher
Feb 08, 2025

Following A -1.03% Weekly Decline, Is It Still A Buy For ProPhase Labs Inc (NASDAQ: PRPH)? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 04, 2025

ProPhase Labs Inc [PRPH] moved up 1.41: Why It’s Important - The DBT News

Feb 04, 2025
pulisher
Feb 03, 2025

PRPH’s Q2 earnings predictions: What the experts say - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

ProPhase Labs Enters into Common Stock Purchase Agreement with Equity Line Investor - Defense World

Feb 03, 2025
pulisher
Feb 01, 2025

ProPhase Labs (NASDAQ:PRPH) Coverage Initiated by Analysts at StockNews.com - Defense World

Feb 01, 2025
pulisher
Jan 30, 2025

ProPhase Labs stock hits 52-week low at $0.41 amid sharp decline - MSN

Jan 30, 2025
pulisher
Jan 29, 2025

ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN

Jan 29, 2025
pulisher
Jan 25, 2025

StockNews.com Initiates Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World

Jan 25, 2025
pulisher
Jan 23, 2025

ProPhase Labs Announces Closing of $23.6 Million Sale of - GlobeNewswire

Jan 23, 2025

Prophase Labs Inc (PRPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research DGX
$167.33
price up icon 0.80%
diagnostics_research LH
$230.02
price down icon 0.71%
$143.94
price down icon 2.94%
diagnostics_research WAT
$362.16
price down icon 2.27%
diagnostics_research MTD
$1,177.09
price down icon 1.36%
diagnostics_research IQV
$177.39
price down icon 1.10%
大文字化:     |  ボリューム (24 時間):